Post-MIS-C cardiovascular outcomes: a systematic review - PubMed
9 hours ago
- #MIS-C
- #cardiovascular outcomes
- #pediatrics
- Systematic review on cardiovascular outcomes post-MIS-C in children.
- 84 studies included (n=4,778), with 7 having comparator groups.
- Cardiovascular abnormalities (e.g., coronary issues, LVEF <55%, myocarditis) mostly resolve by 6-9 months.
- Some subclinical abnormalities (myocardial edema, fibrosis) persist up to 12-24 months.
- MIS-C shows more cardiovascular events and subclinical dysfunction vs. COVID-19/healthy controls.
- MIS-C myocarditis has better outcomes than other myocarditis but lower aerobic capacity.
- Evidence certainty rated very low (GRADE).
- Supports long-term follow-up for MIS-C patients.